Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 27, 2004
Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers
Sabine Colnot, Michiko Niwa-Kawakita, Ghislaine Hamard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2008
The H19 locus acts in vivo as a tumor suppressor
Tomomi Yoshimizu, Audrey Miroglio, Marie-Anne Ripoche, et al.
Development (Cambridge, England)
|
February 18, 2005
Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine
Pauline Andreu, Sabine Colnot, Cécile Godard, et al.
Gut
|
March 21, 2015
Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
Angélique Gougelet, Chiara Sartor, Laura Bachelot, et al.
The Journal of Clinical Investigation
|
January 19, 2012
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice
Marie Anson, Anne-Marie Crain-Denoyelle, Véronique Baud, et al.
Developmental Cell
|
June 3, 2006
Apc tumor suppressor gene is the "zonation-keeper" of mouse liver
Samira Benhamouche, Thomas Decaens, Cécile Godard, et al.
Gut
|
April 14, 2018
β-catenin-activated hepatocellular carcinomas are addicted to fatty acids
Nadia Senni, Mathilde Savall, David Cabrerizo Granados, et al.
Proteomics
|
July 30, 2009
Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway
Philippe Chafey, Laetitia Finzi, Raphael Boisgard, et al.
Plos One
|
December 23, 2015
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
Pierre-Alexandre Just, Alexis Poncy, Sara Charawi, et al.
Journal of Hepatology
|
March 8, 2022
Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth
Robin Loesch, Stefano Caruso, Valérie Paradis, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 27, 2004
Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers
Sabine Colnot, Michiko Niwa-Kawakita, Ghislaine Hamard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2008
The H19 locus acts in vivo as a tumor suppressor
Tomomi Yoshimizu, Audrey Miroglio, Marie-Anne Ripoche, et al.
Development (Cambridge, England)
|
February 18, 2005
Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine
Pauline Andreu, Sabine Colnot, Cécile Godard, et al.
Gut
|
March 21, 2015
Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
Angélique Gougelet, Chiara Sartor, Laura Bachelot, et al.
The Journal of Clinical Investigation
|
January 19, 2012
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice
Marie Anson, Anne-Marie Crain-Denoyelle, Véronique Baud, et al.
Developmental Cell
|
June 3, 2006
Apc tumor suppressor gene is the "zonation-keeper" of mouse liver
Samira Benhamouche, Thomas Decaens, Cécile Godard, et al.
Gut
|
April 14, 2018
β-catenin-activated hepatocellular carcinomas are addicted to fatty acids
Nadia Senni, Mathilde Savall, David Cabrerizo Granados, et al.
Proteomics
|
July 30, 2009
Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway
Philippe Chafey, Laetitia Finzi, Raphael Boisgard, et al.
Plos One
|
December 23, 2015
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
Pierre-Alexandre Just, Alexis Poncy, Sara Charawi, et al.
Journal of Hepatology
|
March 8, 2022
Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth
Robin Loesch, Stefano Caruso, Valérie Paradis, et al.
Page
of 5